for the last few years I have not understood why everyone thought it was so obvious that the drug would be approved. The twice a day has side effects and the weekly drug was only tested in about 200 patients. I do not think the safety database was large enough.
then again why did the fda give them guidance that such a small trial would be acceptable?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.